$NBIX
NEUROCRINE BIOSCIENCES INC Stock $nbix

$nbix Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000091447522000044 Filed on August 04, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$387.9M	$378.2M	$310.6M
YoY Change	31.05%	30.91%	31.28%
Cost Of Revenue	$6.100M	$4.800M	$4.600M
YoY Change	45.24%	54.84%	58.62%
Gross Profit	$381.8M	$373.4M	$306.0M
YoY Change	30.84%	30.65%	30.94%
Gross Profit Margin	98.43%	98.73%	98.52%
Selling, General & Admin	$186.3M	$182.8M	$200.7M
YoY Change	20.5%	27.65%	55.58%
% of Gross Profit	48.8%	48.96%	65.59%
Research & Development	$107.7M	$135.9M	$102.2M
YoY Change	16.18%	81.68%	39.62%
% of Gross Profit	28.21%	36.4%	33.4%
Depreciation & Amortization	$4.000M	$3.900M	$3.300M
YoY Change	42.86%	50.0%	32.0%
% of Gross Profit	1.05%	1.04%	1.08%
Operating Expenses	$294.0M	$318.7M	$302.9M
YoY Change	18.88%	46.19%	49.8%
Operating Profit	$87.80M	$54.70M	$3.100M
YoY Change	97.3%	-12.9%	-90.16%
Interest Expense	$1.200M	$2.200M	$2.600M
YoY Change	-81.82%	-64.52%	-59.38%
% of Operating Profit	1.37%	4.02%	83.87%
Other Income/Expense, Net	$10.10M	-$78.00M	$18.30M
YoY Change	-172.14%	1371.7%	-525.58%
Pretax Income	$97.90M	-$23.30M	$21.40M
YoY Change	220.98%	-140.52%	-21.32%
Income Tax	$29.40M	-$6.400M	$7.500M
% Of Pretax Income	30.03%		35.05%
Net Earnings	$68.50M	-$16.90M	$13.90M
YoY Change	204.44%	-139.95%	-56.7%
Net Earnings / Revenue	17.66%	-4.47%	4.48%
Basic Earnings Per Share	$0.72	-$0.18	$0.15
Diluted Earnings Per Share	$0.69	-$0.18	$0.14
COMMON SHARES
Basic Shares Outstanding	95.64M shares	95.60M shares	95.30M shares
Diluted Shares Outstanding	99.00M shares	95.60M shares	97.60M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$799.4M	$648.3M	$664.9M
YoY Change	4.37%	-26.74%	-23.9%
Cash & Equivalents	$212.2M	$163.3M	$270.2M
Short-Term Investments	$587.2M	$485.0M	$394.7M
Other Short-Term Assets	$67.90M	$62.70M	$60.80M
YoY Change	34.46%	63.28%	79.88%
Inventory	$37.00M	$29.30M	$29.00M
Prepaid Expenses
Receivables	$301.2M	$279.0M	$263.5M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.206B	$1.019B	$1.018B
YoY Change	19.87%	-8.18%	-6.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$60.90M	$66.80M	$63.90M
YoY Change	19.18%	33.6%	41.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$457.5M	$489.0M	$632.3M
YoY Change	-16.67%	29.81%	119.17%
Other Assets	$10.50M	$10.00M	$10.10M
YoY Change	228.13%	212.5%	621.43%
Total Long-Term Assets	$937.9M	$986.4M	$1.126B
YoY Change	-7.29%	16.55%	48.0%
TOTAL ASSETS
Total Short-Term Assets	$1.206B	$1.019B	$1.018B
Total Long-Term Assets	$937.9M	$986.4M	$1.126B
Total Assets	$2.143B	$2.006B	$2.145B
YoY Change	6.25%	2.52%	16.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$297.8M	$265.7M	$235.9M
YoY Change	44.63%	39.18%	37.23%
Accrued Expenses	$17.30M	$17.10M	$16.90M
YoY Change	11.61%	14.0%	38.52%
Deferred Revenue
YoY Change
Short-Term Debt	$169.2M	$0.00	$0.00
YoY Change
Long-Term Debt Due	$169.2M
YoY Change
Total Short-Term Liabilities	$485.1M	$285.7M	$253.5M
YoY Change	114.74%	34.19%	33.42%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$169.0M	$377.7M
YoY Change	-100.0%	-48.21%	17.3%
Other Long-Term Liabilities	$17.10M	$28.00M	$19.70M
YoY Change	106.02%	-3.45%	-7.51%
Total Long-Term Liabilities	$17.10M	$28.00M	$19.70M
YoY Change	106.02%	-3.45%	-7.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$485.1M	$285.7M	$253.5M
Total Long-Term Liabilities	$17.10M	$28.00M	$19.70M
Total Liabilities	$598.8M	$582.3M	$753.4M
YoY Change	-10.8%	-14.01%	17.57%
SHAREHOLDERS EQUITY
Retained Earnings	-$495.8M	-$564.3M	-$547.4M
YoY Change	-21.11%	-13.32%	-21.04%
Common Stock	$2.054B	$2.000B	$1.948B
YoY Change	4.07%	3.65%	2.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.545B	$1.423B	$1.391B
YoY Change
Total Liabilities & Shareholders Equity	$2.143B	$2.006B	$2.145B
YoY Change	6.25%	2.52%	16.14%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	$68.50M	-$16.90M	$13.90M
YoY Change	204.44%	-139.95%	-56.7%
Depreciation, Depletion And Amortization	$4.000M	$3.900M	$3.300M
YoY Change	42.86%	50.0%	32.0%
Cash From Operating Activities	$98.80M	$138.1M	-$40.50M
YoY Change	59.87%	33.82%	-146.39%
INVESTING ACTIVITIES
Capital Expenditures	$1.700M	-$8.800M	$7.600M
YoY Change	-129.82%	104.65%	68.89%
Acquisitions
YoY Change
Other Investing Activities	-$63.00M	$40.20M	-$24.00M
YoY Change	-47.72%	-146.47%	-135.5%
Cash From Investing Activities	-$61.30M	$31.40M	-$31.60M
YoY Change	-51.43%	-134.58%	-150.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$6.100M
YoY Change			-59.87%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	11.40M	-276.4M	$6.100M
YoY Change	52.0%	-9313.33%	-59.6%
NET CHANGE
Cash From Operating Activities	98.80M	138.1M	-$40.50M
Cash From Investing Activities	-61.30M	31.40M	-$31.60M
Cash From Financing Activities	11.40M	-276.4M	$6.100M
Net Change In Cash	48.90M	-106.9M	-$66.00M
YoY Change	-185.94%	-794.16%	-139.88%
FREE CASH FLOW
Cash From Operating Activities	$98.80M	$138.1M	-$40.50M
Capital Expenditures	$1.700M	-$8.800M	$7.600M
Free Cash Flow	$97.10M	$146.9M	-$48.10M
YoY Change	43.85%	36.65%	-158.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0000914475
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2021Q4	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2021Q4	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2021Q4	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2021Q4	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2022Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P13Y7M
CY2021Q4	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-22705
	dei	Entity Registrant Name EntityRegistrantName	NEUROCRINE BIOSCIENCES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address Address Line1 EntityAddressAddressLine1	12780 El Camino Real
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0525145
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92130
	dei	City Area Code CityAreaCode	(858)
	dei	Local Phone Number LocalPhoneNumber	617-7600
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	NBIX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	95639321	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	163300000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	340800000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	485000000.0	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	370500000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	279000000.0	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	185500000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	29300000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	30500000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	62700000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	45500000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1019300000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	972800000	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	328400000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	315100000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	405200000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	560700000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	92200000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	97200000	usd
CY2022Q2	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	83800000	usd
CY2021Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	63700000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	66800000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58600000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10000000.0	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4400000	usd
CY2022Q2	us-gaap	Assets Assets	2005700000	usd
CY2021Q4	us-gaap	Assets Assets	2072500000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	265700000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	225800000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	20000000.0	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	20000000.0	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	285700000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	245800000	usd
CY2022Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	169000000.0	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	335100000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	99600000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	105300000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	28000000.0	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12300000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	582300000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	698500000	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	220000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	220000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	95600000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	95600000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	94900000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	94900000	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1999800000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2011400000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12200000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1700000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-564300000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-635800000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1423400000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1374000000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2005700000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2072500000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	378200000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	288900000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	688800000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	525500000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4800000	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3100000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9400000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6000000.0	usd
CY2022Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	135900000	usd
CY2021Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	74800000	usd
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	238100000	usd
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	148000000.0	usd
CY2022Q2	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	usd
CY2021Q2	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	5000000.0	usd
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	usd
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	5000000.0	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	182800000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	143200000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	383500000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	272200000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	323500000	usd
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	226100000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	631000000.0	usd
	us-gaap	Costs And Expenses CostsAndExpenses	431200000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	54700000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	62800000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	57800000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	94300000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	2200000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	6200000	usd
	us-gaap	Interest Expense InterestExpense	4800000	usd
	us-gaap	Interest Expense InterestExpense	12600000	usd
CY2022Q2	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-7400000	usd
CY2021Q2	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	12500000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	700000	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-70000000.0	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-70000000.0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022Q2	nbix	Investment Income And Other Net InvestmentIncomeAndOtherNet	1600000	usd
CY2021Q2	nbix	Investment Income And Other Net InvestmentIncomeAndOtherNet	900000	usd
	nbix	Investment Income And Other Net InvestmentIncomeAndOtherNet	2600000	usd
	nbix	Investment Income And Other Net InvestmentIncomeAndOtherNet	2300000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-78000000.0	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5300000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-59700000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9600000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23300000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	57500000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1900000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	84700000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6400000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15200000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1100000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10300000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-16900000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	42300000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3000000.0	usd
	us-gaap	Net Income Loss NetIncomeLoss	74400000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2900000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-300000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-10500000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1100000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19800000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	42000000.0	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13500000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	73300000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.45
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95600000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94600000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95400000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94400000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95600000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	97700000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95400000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	98000000.0	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1391100000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-16900000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2900000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	49500000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2600000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1423400000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1205600000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	42300000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-300000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	28600000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3000000.0	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1279200000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1374000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3000000.0	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-10500000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	86500000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8700000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1423400000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1126200000	usd
	us-gaap	Net Income Loss NetIncomeLoss	74400000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1100000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	61500000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	18200000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1279200000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3000000.0	usd
	us-gaap	Net Income Loss NetIncomeLoss	74400000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	86500000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	61500000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-70000000.0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Depreciation Depreciation	7200000	usd
	us-gaap	Depreciation Depreciation	5100000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7900000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	800000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	600000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	12500000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	700000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-3400000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	3300000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	2300000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	5600000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	93500000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1400000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1200000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	300000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	44200000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	29000000.0	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2200000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-5500000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	97600000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	190500000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	253700000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	383100000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	277600000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	364200000	usd
	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	7700000	usd
	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16400000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8800000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-200000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27700000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8700000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18200000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	279000000.0	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	100000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-270300000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18100000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-172900000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	180900000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	344000000.0	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190300000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	171100000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	371200000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	900000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2200000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	21600000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4600000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4300000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	3100000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1600000	usd
CY2022Q2	nbix	Debt Securities Available For Sale Position Number Of Positions DebtSecuritiesAvailableForSalePositionNumberOfPositions	166	security
CY2022Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	164	security
CY2022Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	2700000	usd
CY2021Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	2200000	usd
	us-gaap	Debt Securities Available For Sale Accrued Interest Writeoff DebtSecuritiesAvailableForSaleAccruedInterestWriteoff	0	usd
	us-gaap	Debt Securities Available For Sale Accrued Interest Writeoff DebtSecuritiesAvailableForSaleAccruedInterestWriteoff	0	usd
CY2022Q2	us-gaap	Investments Investments	1145100000	usd
CY2021Q4	us-gaap	Investments Investments	1338900000	usd
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	8000000.0	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	11200000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3400000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3600000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	17900000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	15700000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	29300000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	30500000	usd
CY2022Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	163300000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	368000000.0	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7800000	usd
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	3200000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	171100000	usd
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	371200000	usd
CY2022Q1	nbix	Lessee Operating Lease Option Term To Construct Fifth Building LesseeOperatingLeaseOptionTermToConstructFifthBuilding	P6Y
CY2022Q1	nbix	Rent Abatement Period RentAbatementPeriod	P10M
CY2022Q1	nbix	Lessee Operating Lease Monthly Base Rent Per Square Foot LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot	6	usd
CY2022Q1	nbix	Annual Rent Escalation Percentage AnnualRentEscalationPercentage	0.03
CY2022Q1	nbix	Number Of Renewal Options NumberOfRenewalOptions	2	renewaloption
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7800000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	8200000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	7300000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	8200000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	5500000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y3M18D
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y2M12D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.053
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.053
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	8700000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	17900000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	17400000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	15900000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	15700000	usd
CY2022Q2	nbix	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	70400000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	146000000.0	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	29300000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	116700000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	17100000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	99600000	usd
CY2022Q2	nbix	Non Cancelable Future Minimum Lease Payments For Operating Leases Not Yet Commenced Year Two NonCancelableFutureMinimumLeasePaymentsForOperatingLeasesNotYetCommencedYearTwo	17200000	usd
CY2022Q2	nbix	Non Cancelable Future Minimum Lease Payments For Operating Leases Not Yet Commenced Year Three NonCancelableFutureMinimumLeasePaymentsForOperatingLeasesNotYetCommencedYearThree	33300000	usd
CY2022Q2	nbix	Non Cancelable Future Minimum Lease Payments For Operating Leases Not Yet Commenced Year Four NonCancelableFutureMinimumLeasePaymentsForOperatingLeasesNotYetCommencedYearFour	41900000	usd
CY2022Q2	nbix	Non Cancelable Future Minimum Lease Payments For Operating Leases Not Yet Commenced Year Five NonCancelableFutureMinimumLeasePaymentsForOperatingLeasesNotYetCommencedYearFive	479700000	usd
CY2022Q2	nbix	Debt Instrument Coupon Interest DebtInstrumentCouponInterest	1800000	usd
	nbix	Debt Instrument Coupon Interest DebtInstrumentCouponInterest	4100000	usd
CY2021Q2	nbix	Debt Instrument Coupon Interest DebtInstrumentCouponInterest	1900000	usd
	nbix	Debt Instrument Coupon Interest DebtInstrumentCouponInterest	4000000.0	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	400000	usd
CY2021Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4300000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	800000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8500000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	2200000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	6200000	usd
	us-gaap	Interest Expense InterestExpense	4800000	usd
	us-gaap	Interest Expense InterestExpense	12600000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16900000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16900000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	42300000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	42300000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3000000.0	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3000000.0	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	74400000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	74400000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95600000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94600000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95400000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94400000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95600000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	97700000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95400000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	98000000.0	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.45
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12500000	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4700000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12200000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3700000	shares

Files In Submission

Name	View Source	Status
0000914475-22-000044-index-headers.html	Edgar Link	pending
0000914475-22-000044-index.html	Edgar Link	pending
0000914475-22-000044.txt	Edgar Link	pending
0000914475-22-000044-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nbix-20220630.htm	Edgar Link	pending
nbix-20220630.xsd	Edgar Link	pending
nbix-20220630_cal.xml	Edgar Link	unprocessable
nbix-20220630_def.xml	Edgar Link	unprocessable
nbix-20220630_g1.jpg	Edgar Link	pending
nbix-20220630_htm.xml	Edgar Link	completed
nbix-20220630_lab.xml	Edgar Link	unprocessable
nbix-20220630_pre.xml	Edgar Link	unprocessable
q2-2022xexhibit101.htm	Edgar Link	pending
q2-2022xexhibit102.htm	Edgar Link	pending
q2-2022xexhibit103.htm	Edgar Link	pending
q2-2022xexhibit311.htm	Edgar Link	pending
q2-2022xexhibit312.htm	Edgar Link	pending
q2-2022xexhibit32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NBIX
NEUROCRINE BIOSCIENCES INC Stock $nbix

2022 Q3 Form 10-Q Financial Statement

#000091447522000044 Filed on August 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NBIX NEUROCRINE BIOSCIENCES INC Stock $nbix

2022 Q3 Form 10-Q Financial Statement

#000091447522000044 Filed on August 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NBIX
NEUROCRINE BIOSCIENCES INC Stock $nbix